XAIR
- Beyond Air, Inc.
()
Overview
Company Summary
Beyond Air, Inc. (XAIR) is a medical technology company that specializes in the development and commercialization of innovative pharmaceutical and medical device products for the treatment of various respiratory conditions. The company primarily focuses on utilizing its proprietary technology to develop advanced systems that deliver high concentrations of nitric oxide (NO) gas.
Nitric oxide is a naturally occurring molecule in the human body that plays a crucial role in various physiological processes, especially in the respiratory system. Beyond Air has harnessed the therapeutic potential of nitric oxide to develop solutions for respiratory conditions such as bronchiolitis, pneumonia, chronic obstructive pulmonary disease (COPD), and other respiratory infections.
The company's flagship product, the LungFit� system, is a portable and easy-to-use medical device that generates and delivers precise amounts of NO gas to the lungs. This system is designed to target and eliminate harmful bacteria, viruses, and fungi that cause respiratory infections. By delivering high concentrations of nitric oxide directly to the lungs, the LungFit� system aims to improve patient outcomes and reduce the reliance on antibiotics, which can lead to antibiotic resistance.
Beyond Air is continuously working on expanding its product portfolio and exploring the potential applications of nitric oxide therapy across various respiratory conditions. The company's dedicated research and development efforts aim to bring new, safe, and effective treatment options to healthcare professionals and patients in need.
In addition to its product development focus, Beyond Air also collaborates with leading medical institutions and research organizations to conduct clinical trials, gather scientific data, and further enhance the understanding of nitric oxide therapy. This commitment to research and collaboration ensures that the company stays at the forefront of respiratory healthcare innovation.
Overall, Beyond Air, Inc. is committed to advancing respiratory care through its innovative nitric oxide-based technologies, ultimately improving patient outcomes and transforming the way respiratory conditions are treated.